Table III.
Univariate dyad and social network correlates of disclosure of being HCV- and HIV-infected.
Characteristic | Hungary HCV disclosure Dyad n = 94 |
Lithuania – non-Russian HCV disclosure Dyad n = 518 |
Lithuania – Russian HCV disclosure Dyad n = 616 |
Lithuania HIV disclosure Dyad n = 138 |
||||
---|---|---|---|---|---|---|---|---|
Did not disclose | Disclosed | Did not disclose | Disclosed | Did not disclose | Disclosed | Did not disclose | Disclosed | |
Total | 16 (17.0) | 78 (83.0) | 104 (20.1) | 414 (79.9) | 124 (20.1) | 492 (79.9) | 92 (66.7) | 46 (33.3) |
Dyad characteristics | ||||||||
Age of network member y, mean (SD) | 29.8 (5.7) | 28.7 (5.1) | 30.0 (6.8) | 31.2 (6.9) | 29.8 (7.2) | 29.9 (6.5) | 32.4 (6.5) | 32.8 (6.0) a |
Female | ||||||||
No | 13 (17.8) | 60 (82.2) | 70 (18.4) | 310 (81.6) | 96 (19.9) | 386 (80.1) | 70 (64.2) | 39 (35.8) |
Yes | 3 (14.3) | 18 (85.7) | 34 (24.6) | 104 (75.4) | 28 (20.9) | 106 (79.1) | 22 (75.9) | 7 (24.1) |
Roma ethnicity | ||||||||
No | 12 (15.2) | 67 (84.8) | 98 (19.4) | 408 (80.6) | 122 (20.2) | 483 (79.8) | 92 (67.6) | 44 (32.4) |
Yes | 4 (26.7) | 11 (73.3) | 6 (50.0) | 6 (50.0) a | 2 (18.2) | 9 (81.8) | 0 (0) | 2 (100) |
Russian ethnicity | N/A | |||||||
No | 48 (19.7) | 196 (80.3) | 58 (25.1) | 173 (74.9) | 34 (64.2) | 19 (35.8) | ||
Yes | 56 (20.4) | 218 (79.6) | 66 (17.1) | 319 (82.9) a | 58 (68.2) | 27 (31.8) | ||
Polish ethnicity | N/A | |||||||
No | 91 (20.4) | 354 (79.6) | 107 (20.4) | 418 (79.6) | 73 (66.4) | 37 (33.6) | ||
Yes | 13 (17.8) | 60 (82.2) | 17 (18.7) | 74 (81.3) | 19 (67.9) | 9 (32.1) | ||
Network member is HCV-infected | ||||||||
No | 12 (20.3) | 47 (79.7) | 36 (66.7) | 18 (33.3) | 33 (54.1) | 28 (45.9) | 1 (100) | 0 (0) |
Yes | 4 (11.4) | 31 (88.6) | 68 (14.7) | 396 (85.3) a | 91 (16.4) | 464 (83.6) a | 91 (66.4) | 46 (33.6) |
Network member is HIV-infected | ||||||||
No | 0 | 0 | 99 (20.5) | 384 (79.5) | 116 (19.9) | 466 (80.1) | 83 (72.8) | 31 (27.2) |
Yes | 0 | 0 | 5 (14.3) | 30 (85.7) | 8 (23.5) | 26 (76.5) | 9 (37.5) | 15 (62.5) a |
Emotionally close | ||||||||
No | 11 (24.4) | 34 (75.6) | 87 (25.1) | 259 (74.9) | 107 (25.2) | 318 (74.8) | 75 (76.5) | 23 (23.5) |
Yes | 5 (10.2) | 44 (89.8) | 17 (9.9) | 155 (90.1) a | 17 (8.9) | 174 (91.1) a | 17 (42.5) | 23 (57.5) a |
Length of time knowing each other in months, mean (SD) | 90.9 (60.0) | 82.3 (71.5) | 22.1 (17.4) | 38.9 (50.3) a | 20.7 (17.0) | 31.6 (39.1) a | 29.2 (20.3) | 37.5 (59.6) |
Daily contact | ||||||||
No | 11 (22.0) | 39 (78.0) | 85 (24.4) | 263 (75.6) | 106 (23.4) | 347 (76.6) | 87 (73.1) | 32 (26.9) |
Yes | 5 (11.4) | 39 (88.6) | 19 (11.2) | 151 (88.8) | 18 (11.0) | 145 (89.0) a | 5 (26.3) | 14 (73.7) a |
Used drugs together | ||||||||
No | 5 (41.7) | 7 (58.3) | 15 (39.5) | 23 (60.5) | 12 (37.5) | 20 (62.5) | 0 (0) | 2 (100) |
Yes | 11 (13.4) | 71 (86.6) a | 89 (18.5) | 391 (81.5) | 112 (19.2) | 472 (80.8) | 92 (67.6) | 44 (32.4) |
Number of times injected drugs together in past 30 days, mean (SD) | 9.9 (15.9) | 13.3 (18.6) | 9.6 (12.8) | 14.1 (9.5) | 9.4 (6.5) | 13.9 (10.4) a | 8.7 (4.8) | 11.1 (5.7) |
Sharing of cookers, filters, drug solutions or rinse water | ||||||||
No | 9 (20.1) | 34 (79.1) | 63 (38.4) | 101 (61.6) | 57 (33.5) | 113 (66.5) | 35 (59.3) | 24 (40.7) |
Yes | 7 (13.7) | 44 (86.3) | 41 (11.6) | 313 (88.4) a | 67 (15.0) | 379 (85.0) a | 57 (72.2) | 22 (27.8) |
Distributive syringe sharing | ||||||||
No | 16 (19.8) | 65 (80.2) | 74 (28.4) | 187 (71.6) | 81 (25.4) | 238 (74.6) | 91 (68.9) | 41 (31.1) |
Yes | 0 (0) | 13 (100) | 30 (11.7) | 227 (88.3) a | 43 (14.5) | 254 (85.5) a | 1 (16.7) | 5 (83.3) |
Receptive syringe sharing | ||||||||
No | 15 (18.3) | 67 (81.7) | 92 (31.7) | 198 (68.3) | 103 (27.6) | 270 (72.4) | 43 (60.6) | 28 (39.4) |
Yes | 1 (8.3) | 11 (91.7) | 12 (5.3) | 216 (94.7) a | 21 (8.6) | 222 (91.4) a | 49 (73.1) | 18 (26.9) |
Number of times they had sex in the past 30 days, mean (SD) | 0.13 (0.34) | 0.97 (2.91) a | 0.09 (0.40) | 0.39 (1.86) | 0.47 (1.71) | 0.68 (2.61) | 0.02 (0.21) | 0.78 (2.67) a |
Social network characteristics | ||||||||
Size of nominated network of never-injectors, mean (SD) | 0.94 (0.68) | 0.69 (1.10) | 0.57 (1.35) | 0.20 (0.63) a | 0.80 (1.41) | 0.17 (0.62) a | 0.34 (1.22) | 0.28 (1.07) |
Two or more never-injector network members keep in touch with each other (density) | ||||||||
No | 16 (18.0) | 73 (82.0) | 89 (18.2) | 400 (81.8) | 104 (17.7) | 484 (82.3) | 85 (65.4) | 45 (34.6) |
Yes | 0 (0) | 5 (100) | 15 (51.7) | 14 (48.3) a | 20 (71.4) | 8 (28.6) a | 7 (87.5) | 1 (12.5) |
Size of nominated network of ever-injectors, mean (SD) | 4.9 (2.5) | 4.1 (2.3) | 5.6 (1.6) | 5.1 (1.7) | 5.5 (2.0) | 5.4 (1.9) | 6.0 (1.7) | 5.3 (1.8) |
2 or more ever-injector network members keep in touch with each other (density) | ||||||||
No | 4 (13.3) | 26 (86.7) | 8 (24.2) | 25 (75.8) | 7 (36.8) | 12 (63.2) | 4 (50.0) | 4 (50.0) |
Yes | 12 (18.8) | 52 (81.3) | 96 (19.8) | 389 (80.2) | 117 (19.6) | 480 (80.4) | 88 (67.7) | 42 (32.3) |
SD, standard deviation; N/A, not applicable; HCV, hepatitis C virus; HIV, human immunodeficiency virus. Percentages are row percentages.
p < 0.05.